Owens DM - Search Results

1

Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.

Arnott CH, Scott KA, Moore RJ, Hewer A, Phillips DH, Parker P, Balkwill FR, Owens DM. Arnott CH, et al. Among authors: owens dm. Oncogene. 2002 Jul 18;21(31):4728-38. doi: 10.1038/sj.onc.1205588. Oncogene. 2002. PMID: 12101411

2

Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F. Moore RJ, et al. Among authors: owens dm. Nat Med. 1999 Jul;5(7):828-31. doi: 10.1038/10552. Nat Med. 1999. PMID: 10395330

3

A multihit, multistage model of chemical carcinogenesis.

Owens DM, Wei S, Smart RC. Owens DM, et al. Carcinogenesis. 1999 Sep;20(9):1837-44. doi: 10.1093/carcin/20.9.1837. Carcinogenesis. 1999. PMID: 10469632

4

Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.

Owens DM, Spalding JW, Tennant RW, Smart RC. Owens DM, et al. Cancer Res. 1995 Jul 15;55(14):3171-8. Cancer Res. 1995. PMID: 7606738

5

Localization and expression of cornifin-alpha/SPRR1 in mouse epidermis, anagen hair follicles, and skin neoplasms.

Owens DM, Zainal TA, Jetten AM, Smart RC. Owens DM, et al. J Invest Dermatol. 1996 Apr;106(4):647-54. doi: 10.1111/1523-1747.ep12345463. J Invest Dermatol. 1996. PMID: 8617999 Free article.

6

C/EBPα expression is downregulated in human nonmelanoma skin cancers and inactivation of C/EBPα confers susceptibility to UVB-induced skin squamous cell carcinomas.

Thompson EA, Zhu S, Hall JR, House JS, Ranjan R, Burr JA, He YY, Owens DM, Smart RC. Thompson EA, et al. Among authors: owens dm. J Invest Dermatol. 2011 Jun;131(6):1339-46. doi: 10.1038/jid.2011.31. Epub 2011 Feb 24. J Invest Dermatol. 2011. PMID: 21346772 Free PMC article.

7

GET: a foundation model of transcription across human cell types.

Fu X, Mo S, Buendia A, Laurent A, Shao A, Del Mar Alvarez-Torres M, Yu T, Tan J, Su J, Sagatelian R, Ferrando AA, Ciccia A, Lan Y, Owens DM, Palomero T, Xing EP, Rabadan R. Fu X, et al. Among authors: owens dm. bioRxiv [Preprint]. 2024 Jul 3:2023.09.24.559168. doi: 10.1101/2023.09.24.559168. bioRxiv. 2024. PMID: 39005360 Free PMC article. Preprint.

8

The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma.

Morgado-Palacin L, Brown JA, Martinez TF, Garcia-Pedrero JM, Forouhar F, Quinn SA, Reglero C, Vaughan J, Heydary YH, Donaldson C, Rodriguez-Perales S, Allonca E, Granda-Diaz R, Fernandez AF, Fraga MF, Kim AL, Santos-Juanes J, Owens DM, Rodrigo JP, Saghatelian A, Ferrando AA. Morgado-Palacin L, et al. Among authors: owens dm. Nat Commun. 2023 Mar 10;14(1):1328. doi: 10.1038/s41467-023-36713-8. Nat Commun. 2023. PMID: 36899004 Free PMC article.

9

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy.

Shao A, Owens DM. Shao A, et al. Among authors: owens dm. Oncotarget. 2023 Feb 4;14:96-103. doi: 10.18632/oncotarget.28354. Oncotarget. 2023. PMID: 36738455 Free PMC article. Review.

10

Tbc1d10c is a selective, constitutive suppressor of the CD8 T-cell anti-tumor response.

Cohen AO, Woo SH, Zhang J, Cho J, Ruiz ME, Gong J, Du R, Yarygina O, Jafri DZ, Bachelor MA, Finlayson MO, Soni RK, Hayden MS, Owens DM. Cohen AO, et al. Among authors: owens dm. Oncoimmunology. 2022 Nov 2;11(1):2141011. doi: 10.1080/2162402X.2022.2141011. eCollection 2022. Oncoimmunology. 2022. PMID: 36338148 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters